Institutional investors purchased a net $1.7 million shares of ALIM during the quarter ended June 2014, and now own 40.46% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTH RUN CAPITAL LP Bought 334.4 Thousand shares of Alimera Sciences Inc
BLACKROCK FUND ADVISORS Bought 230.5 Thousand shares of Alimera Sciences Inc
AURIGA CAPITAL MANAGEMENT LLC Bought 190.0 Thousand shares of Alimera Sciences Inc